Leiomyoma: Difference between revisions
Jump to navigation
Jump to search
Shanshan Cen (talk | contribs) No edit summary |
Shanshan Cen (talk | contribs) No edit summary |
||
| Line 5: | Line 5: | ||
{{CMG}}; {{AE}} {{CZ}} {{SC}} | {{CMG}}; {{AE}} {{CZ}} {{SC}} | ||
{{SK}} | |||
==[[Leiomyoma overview|Overview]]== | ==[[Leiomyoma overview|Overview]]== | ||
Revision as of 19:56, 8 December 2015
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2] Shanshan Cen, M.D. [3]
Synonyms and keywords:
Overview
Historical Perspective
Classification
Pathophysiology
Differentiating Leiomyoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies | Biopsy
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies